Wird geladen...
Therapeutic Aptamers: Evolving to Find their Clinical Niche
BACKGROUND: The discovery that short oligonucleotides, termed aptamers, can fold into three-dimensional structures that allow them to selectively bind and inhibit the activity of pathogenic proteins is now over 25 years old. The invention of the SELEX methodology heralded in an era in which such nuc...
Gespeichert in:
| Veröffentlicht in: | Curr Med Chem |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8177732/ https://ncbi.nlm.nih.gov/pubmed/31573879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/0929867326666191001125101 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|